Skip to content
lifestyle.mmminimal.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Genmab A/S
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
July 15, 2026
Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival
June 29, 2026
Major Shareholder Announcement
June 15, 2026
Major Shareholder Announcement
May 8, 2026
Genmab Announces Financial Results for the First Quarter of 2026
May 7, 2026
Major Shareholder Announcement
April 14, 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
April 14, 2026
Major Shareholder Announcement
April 1, 2026
Major Shareholder Announcement
March 30, 2026
Genmab Publishes 2025 Annual Report
February 17, 2026